|
C4ORF42 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.578010E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.329700E-02 |
| Normal-vs-Stage2 |
8.786800E-01 |
| Normal-vs-Stage3 |
7.627900E-02 |
| Normal-vs-Stage4 |
6.726400E-01 |
| Stage1-vs-Stage2 |
2.301800E-01 |
| Stage1-vs-Stage3 |
8.980400E-01 |
| Stage1-vs-Stage4 |
2.148400E-02 |
| Stage2-vs-Stage3 |
2.326000E-01 |
| Stage2-vs-Stage4 |
6.259000E-01 |
| Stage3-vs-Stage4 |
3.423700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.886100E-02 |
| Normal-vs-AfricanAmerican |
4.883600E-02 |
| Normal-vs-Asian |
9.503400E-01 |
| Caucasian-vs-AfricanAmerican |
4.224500E-04 |
| Caucasian-vs-Asian |
6.374200E-02 |
| AfricanAmerican-vs-Asian |
6.656400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.708400E-01 |
| Normal-vs-Female |
1.020960E-01 |
| Male-vs-Female |
2.798600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.213700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.945800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.407400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.131600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.084800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.016200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.697400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.150000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.874000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.350000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.204600E-01 |
| Classical-VS-Follicular |
5.390700E-04 |
| Classical-VS-Other |
1.078780E-01 |
| Classical-VS-Normal |
7.455200E-01 |
| Tall-VS-Follicular |
2.739600E-01 |
| Tall-VS-Other |
3.626800E-01 |
| Tall-VS-Normal |
2.020200E-01 |
| Follicular-VS-Other |
8.115400E-01 |
| Follicular-VS-Normal |
6.541500E-03 |
| Other-VS-Normal |
1.004780E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.193600E-02 |
| Normal-vs-N1 |
9.839800E-02 |
| N0-vs-N1 |
7.849200E-01 |
|
|
